Repligen Reports Financial Results for the Year 2014 and Issues 2015 Financial Guidance

Go back to Repligen Reports Financial Results for the Year 2014 and Issues 2015 Financial Guidance

Repligen (RGEN) Posts Q4 Loss of 1c/Share

March 13, 2015 7:01 AM EDT

Repligen (NASDAQ: RGEN) reported Q4 EPS of ($0.01), $0.05 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $15.4 million versus the consensus estimate of $14.7 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

... More